Leerink Partners analyst Mani Foroohar has maintained their bullish stance on CRSP stock, giving a Buy rating on January 13.Stay Ahead of the ...

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $38.36, moving -1.26% from the previous trading session.

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Crispr Therapeutics AG (CRSP) stock saw a decline, ending the day at $38.85 which represents a decrease of $-0.84 or -2.12% from the prior close of $39.69. The stock opened at $39.06 and touched a low ...

Citing positive developments in its development programs, analysts from a couple of investment banks think CRISPR Therapeutics(NASDAQ: CRSP) could more than double your money in the year ahead. Start ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends ...

Researchers in the group of Associate Professor Ninib Baryawno, Department of Women's and Children's Health, KI, have ...

Check the time stamp on this data. Updated AI-Generated Signals for Crispr Therapeutics Ag (CRSP) available here: CRSP. Type ...

In a report released today, Alec Stranahan from Bank of America Securities maintained a Buy rating on Caribou Biosciences (CRBU – Research ...

A research team led by Prof. Feng Wei at the Institute of Biophysics, Chinese Academy of Sciences, has made significant ...

A study concluded that the use of over-the-counter pain relievers is more effective than opioids for pain management after ...